Shares of insurance brokerage firm Brown & Brown (NYSE:BRO) fell 7.3% in the afternoon session after the company reported mixed fourth-quarter 2025 results, with an earnings beat failing to offset a shortfall in revenue.
Growth is oxygen.
But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
Insurance brokerage firm Brown & Brown (NYSE:BRO) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 36% year on year to $1.61 billion. Its non-GAAP profit of $0.93 per share was 3.3% above analysts’ consensus estimates.
Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Brown & Brown (NYSE:BRO) and the best and worst performers in the insurance brokers industry.
Shareholders of Brown & Brown would probably like to forget the past six months even happened. The stock dropped 26.1% and now trades at $79.26. This may have investors wondering how to approach the situation.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how insurance brokers stocks fared in Q3, starting with Arthur J. Gallagher (NYSE:AJG).
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities.
However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the insurance brokers industry, including Ryan Specialty (NYSE:RYAN) and its peers.
Insurance brokerage firm Brown & Brown (NYSE:BRO) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 35.4% year on year to $1.61 billion largely due to M&A and profit-sharing contingent commissions. Its non-GAAP profit of $1.05 per share was 12.9% above analysts’ consensus estimates.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session.
